Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Ordinary Shares, par value GBP 0.001 per share
-
Shares outstanding
-
1,571,428,571
-
Total 13F shares
-
20,950,250
-
Share change
-
+20,471,396
-
Total reported value
-
$384,020,000
-
Price per share
-
$18.33
-
Number of holders
-
45
-
Value change
-
+$375,243,000
-
Number of buys
-
44
Institutional Holders of Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAPY) as of Q2 2015
As of 30 Jun 2015 Adaptimmune Therapeutics PLC - Ordinary Shares, par value GBP 0.001 per share (ADAPY) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,950,250 shares of stock of the company.
Largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, Novo A/S, Foresite Capital Management II, LLC, Capital World Investors, Partner Fund Management, L.P., Rock Springs Capital Management LP, ARROWGRASS CAPITAL PARTNERS (US) LP, QVT Financial LP, and JENNISON ASSOCIATES LLC.
This table shows 45 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.